Multispecific Antibody Assembly via Segmented Single-Domain Modules
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating bispecific protein complexes are inefficient and labor-intensive, requiring extensive cloning, expression, and purification steps, limiting high-throughput screening for novel antigen pairs and synergistic biological functions.
Innovation Solution
A multispecific protein complex format where individual components are expressed as units and assembled via mixing, without conjugation or coupling chemistry, minimizing homodimerization, allowing for the rapid generation and screening of diverse bispecific antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If traditional bispecific antibody formats are used, then functional versatility is improved, but manufacturing complexity and time increase significantly
Solution Approach 1:
The patent segments the bispecific antibody into separate single-domain antibody (sdAb) modules that can be independently expressed and then assembled. This modular approach allows each sdAb to be produced separately in high throughput, then combined through simple mixing rather than complex conjugation chemistry, thereby reducing manufacturing complexity while maintaining functional versatility.
Solution Approach 2:
The patent performs preliminary action by pre-expressing and purifying individual sdAb components before assembly. This allows each component to be optimized and produced independently in advance, enabling high-throughput screening of different sdAb combinations without requiring complex simultaneous expression systems, thus reducing overall manufacturing complexity.
2Adaptability or versatility
If extensive cloning and expression steps are performed, then bispecific antibody diversity increases, but productivity decreases
Solution Approach 1:
By segmenting the bispecific antibody into separate sdAb modules, the patent enables independent cloning and expression of each module. This allows parallel processing of multiple sdAb variants, dramatically increasing screening throughput while maintaining the ability to generate diverse bispecific combinations through simple mixing of the modular components.
Solution Approach 2:
The patent merges the diversity generation step with the assembly step by allowing multiple sdAb variants to be expressed independently and then combined through simple mixing. This eliminates the need for complex conjugation procedures for each combination, thereby maintaining high antibody diversity while significantly improving productivity and screening throughput.
3Manufacturing precision
If conjugation or coupling chemistry is used, then assembly precision improves, but manufacturing time and complexity increase
Solution Approach 1:
The patent extracts the complex conjugation or coupling chemistry steps from the assembly process. Instead of using chemical crosslinking or complex fusion protein systems, the invention uses simple physical mixing of sdAb modules that self-assemble based on their inherent binding properties, thereby maintaining assembly precision while dramatically reducing manufacturing time and complexity.
Solution Approach 2:
The patent introduces a simplified intermediary mechanism where sdAb modules with complementary binding properties serve as natural mediators for assembly. Rather than requiring external chemical conjugation reagents or complex fusion protein intermediaries, the sdAb modules themselves mediate the assembly process through their specific binding interactions, reducing both time and complexity.
4Manufacturing precision
If homodimerization is minimized, then bisspecific purity improves, but assembly efficiency may decrease
Solution Approach 1:
The patent applies asymmetry by designing sdAb modules with non-complementary binding interfaces that specifically recognize each other in a heterodimeric configuration. This asymmetric design prevents homodimerization while ensuring efficient heterodimer assembly, thereby improving bisspecific purity without sacrificing assembly efficiency. The asymmetric binding interfaces act as molecular recognition elements that guide correct assembly.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables efficient and high-throughput screening of bispecific antibodies by simplifying the assembly process, reducing purification requirements, and ensuring high yield and purity of desired bispecific protein complexes, facilitating the identification of synergistic biological functions.
Implementation Method 1
X:Y is a heterodimeric-tether; : is a binding interaction between X and Y
Data Source
AI summary
The present invention relates to heterodimerically-tethered bispecific protein complexes (according to the general formula of A(A1)n-X:Y-B(B1)m and libraries/multiplexes thereof for use in research and therapy and in particular an in vitro/ex vivo method of detecting synergistic biological function of otherwise unknown pairs of targets. Such complexes may be used to capture soluble molecules secreted from a particular cell, in therapy, in research and for experimental purposes such as in assays to characterise patient populations by identifying cell populations relevant to a pathology or prognosis.